IL-22 Is Produced by Innate Lymphoid Cells and Limits Inflammation in Allergic Airway Disease
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Interleukin (IL)-22 is an effector cytokine, which acts primarily on epithelial cells in the skin, gut, liver and lung. Both pro- and anti-inflammatory properties have been reported for IL-22 depending on the tissue and disease model. In a murine model of allergic airway inflammation, we found that IL-22 is predominantly produced by innate lymphoid cells in the inflamed lungs, rather than TH cells. To determine the impact of IL-22 on airway inflammation, we used allergen-sensitized IL-22-deficient mice and found that they suffer from significantly higher airway hyperreactivity upon airway challenge. IL-22-deficiency led to increased eosinophil infiltration lymphocyte invasion and production of CCL17 (TARC), IL-5 and IL-13 in the lung. Mice treated with IL-22 before antigen challenge displayed reduced expression of CCL17 and IL-13 and significant amelioration of airway constriction and inflammation. We conclude that innate IL-22 limits airway inflammation, tissue damage and clinical decline in allergic lung disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus
Srinivas, S., Watanabe, T., Lin, C.-S., William, C. M., Tanabe, Y., Jessell, T. M., & Costantini, F. (2001) · BMC Developmental Biology · doi:10.1186/1471-213x-1-4 · Cited by 3,121 · cited 1×
“Rosa26-stop-eYFP mice [50] (called ‘Rorc-eYFP mice’ here) [51]”
The development of allergic inflammation
Galli, S. J., Tsai, M., & Piliponsky, A. M. (2008) · Nature · doi:10.1038/nature07204 · Cited by 1,839 · cited 7×
“C22 cells were pretreated with or without IL-22 and subsequently stimulated with IL-13, TNF, or a combination of both.”
BackgroundInfluentialInterleukin‐10: new perspectives on an old cytokine
Mosser, D. M., & Zhang, X. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00706.x · Cited by 1,077
STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing
Pickert, G., Neufert, C., Leppkes, M., Zheng, Y., Wittkopf, N., Warntjen, M., Lehr, H.-A., Hirth, S., Weigmann, B., Wirtz, S., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082683 · Cited by 1,043 · cited 1×
“Additionally, IL-22 has been shown to play a protective role in different models of inflammatory bowel disease [9].”
Backgroundγδ T cell effector functions: a blend of innate programming and acquired plasticity
Bonneville, M., O'Brien, R. L., & Born, W. K. (2010) · Nature Reviews Immunology · doi:10.1038/nri2781 · Cited by 952
Boniface, K., Bernard, F.-X., Garcia, M., Gurney, A. L., Lecron, J.-C., & Morel, F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3695 · Cited by 864
Kawasaki, S., Takizawa, H., Yoneyama, H., Nakayama, T., Fujisawa, R., Izumizaki, M., Imai, T., Yoshie, O., Homma, I., Yamamoto, K., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.3.2055 · Cited by 261 · cited 2×
“T cell recruitment into the lung during allergic airway disease has been linked to chemokines, including CCL17 [26].”
BackgroundWhittington (2004) · doi:10.1165/rcmb.2003-0285oc · Cited by 130
Cited by
The biology of innate lymphoid cells
Artis, D., & Spits, H. (2015) · Nature · doi:10.1038/nature14189 · Cited by 1,634
Interleukin-22: Immunobiology and Pathology
Dudakov, J. A., Hanash, A. M., & van den Brink, M. R. M. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112123 · Cited by 905
Gut–Liver Axis in Alcoholic Liver Disease
Szabo, G. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.10.042 · Cited by 754
Innate Lymphoid Cells: Emerging Insights in Development, Lineage Relationships, and Function
Spits, H., & Cupedo, T. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075053 · Cited by 693
Innate lymphoid cells — how did we miss them?
Walker, J. A., Barlow, J. L., & McKenzie, A. N. J. (2013) · Nature Reviews Immunology · doi:10.1038/nri3349 · Cited by 669
Therapeutic opportunities of the IL-22–IL-22R1 system
Sabat, R., Ouyang, W., & Wolk, K. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4176 · Cited by 562
Hazenberg, M. D., & Spits, H. (2014) · Blood · doi:10.1182/blood-2013-11-427781 · Cited by 374
IL-22 Is Essential for Lung Epithelial Repair following Influenza Infection
Pociask, D. A., Scheller, E. V., Mandalapu, S., McHugh, K. J., Enelow, R. I., Fattman, C. L., Kolls, J. K., & Alcorn, J. F. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.12.007 · Cited by 220
Gray, J., Oehrle, K., Worthen, G., Alenghat, T., Whitsett, J., & Deshmukh, H. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf9412 · Cited by 215
A comprehensive review of the nasal microbiome in chronic rhinosinusitis (CRS)
Mahdavinia, M., Keshavarzian, A., Tobin, M. C., Landay, A. L., & Schleimer, R. P. (2016) · Clinical & Experimental Allergy · doi:10.1111/cea.12666 · Cited by 165
The origin and role of innate lymphoid cells in the lung
Lai, D.-M., Shu, Q., & Fan, J. (2016) · Military Medical Research · doi:10.1186/s40779-016-0093-2 · Cited by 45
“maintenance of lung epithelial cell function and in the negative regulation of lung inflammation [67, 68].”
BackgroundThe role of IL‐22 in the resolution of sterile and nonsterile inflammation
Alabbas, S. Y., Begun, J., Florin, T. H., & Oancea, I. (2018) · Clinical & Translational Immunology · doi:10.1002/cti2.1017 · Cited by 37
“1– 10 mg kg (1).(78) Unlike the smoke inhalation study, the finding of rIL-22 protection was supported by IL22 KO mice, which developed more inflammation following methacholine challenge.”
Background
Metadata
- Authors
- Taube, C., Tertilt, C., Gyülveszi, G., Dehzad, N., Kreymborg, K., Schneeweiss, K., Michel, E., Reuter, S., Renauld, J.-C., Arnold-Schild, D., Schild, H., Buhl, R., & Becher, B.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-07-18
- Volume
- 6
- Issue
- 7
- Pages
- e21799
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2084196437
- Cited by
- 134
- References
- 8
- FWCI
- 5.77
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.